Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -10.85% is 75% above its 5-year average of -42.67%, near the high end of its 5-year range (-132.66%–-5.77%).
As of the fiscal period ended Tuesday, June 30, 2026. 18.33% below its 12-month average of -9.17%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q1 FY2027 (2026-06-30): -10.85%.
RETURN ON INVESTED CAPITAL (ROIC)
-10.85%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-9.17%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-13.96%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-42.67%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-13.69%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
-12.10%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-18.33%
CURRENT VS 3Y AVG
+22.28%
CURRENT VS 5Y AVG
+74.58%
CURRENT VS 10Y AVG
+20.75%
CURRENT VS 15Y AVG
+10.33%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-28.79%
median of 492 covered companies
CURRENT VS SECTOR MEDIAN
+62.31%
vs the sector median at left
Canopy Growth Corporation
Market Cap
$373.40M
Return on Invested Capital (ROIC)
-10.85%
TTM Avg
-9.17%
3Y Avg
-13.96%
5Y Avg
-42.67%
Market Cap
$368.91M
Return on Invested Capital (ROIC)
-1.84%
TTM Avg
-2.07%
3Y Avg
-43.39%
5Y Avg
-53.01%
Market Cap
$366.39M
Return on Invested Capital (ROIC)
-24.20%
TTM Avg
-33.45%
3Y Avg
-34.14%
5Y Avg
-28.75%
Market Cap
$363.54M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-35.18%
3Y Avg
-129.73%
5Y Avg
-103.61%
Market Cap
$384.23M
Return on Invested Capital (ROIC)
-80.67%
TTM Avg
-59.31%
3Y Avg
-71.22%
5Y Avg
-64.55%
Market Cap
$361.64M
Return on Invested Capital (ROIC)
-59.29%
TTM Avg
-166.84%
3Y Avg
-79.03%
5Y Avg
-92.27%
Market Cap
$348.85M
Return on Invested Capital (ROIC)
17.99%
TTM Avg
23.20%
3Y Avg
26.35%
5Y Avg
40.47%
Market Cap
$348.59M
Return on Invested Capital (ROIC)
-27.16%
TTM Avg
-54.52%
3Y Avg
-49.44%
5Y Avg
-51.83%
Market Cap
$345.48M
Return on Invested Capital (ROIC)
-40.51%
TTM Avg
-48.13%
3Y Avg
-48.38%
5Y Avg
-39.85%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Canopy Growth Corporation (CGC) | $373.40M | -10.85% | -9.17% | -13.96% | -42.67% |
| Fennec Pharmaceuticals Inc. (FENC)vs › | $368.91M | -1.84% | -2.07% | -43.39% | -53.01% |
| Enanta Pharmaceuticals, Inc. (ENTA)vs › | $366.39M | -24.20% | -33.45% | -34.14% | -28.75% |
| Agenus Inc. (AGEN)vs › | $363.54M | N/A | -35.18% | -129.73% | -103.61% |
| Kyverna Therapeutics, Inc. (KYTX)vs › | $384.23M | -80.67% | -59.31% | -71.22% | -64.55% |
| Opus Genetics, Inc. (IRD)vs › | $361.64M | -59.29% | -166.84% | -79.03% | -92.27% |
| Embecta Corp. (EMBC)vs › | $348.85M | 17.99% | 23.20% | 26.35% | 40.47% |
| Artiva Biotherapeutics, Inc. (ARTV)vs › | $348.59M | -27.16% | -54.52% | -49.44% | -51.83% |
| ClearPoint Neuro, Inc. (CLPT)vs › | $345.48M | -40.51% | -48.13% | -48.38% | -39.85% |
| Shoulder Innovations, Inc. (SI)vs › | $406.47M | -25.26% | -29.12% | -26.65% | -26.65% |
ROIC
-10.8%
ROE
-38.6%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -10.85% |
| 2026-03-31 | -10.66% |
| 2025-12-31 | -5.77% |
| 2025-09-30 | -6.80% |
| 2025-06-30 | -11.76% |
| 2025-03-31 | -13.02% |
| 2024-12-31 | -20.27% |
| 2024-09-30 | -22.33% |
| 2024-06-30 | -18.39% |
| 2024-03-31 | -19.75% |
| 2023-12-31 | -64.13% |
| 2023-09-30 | -56.47% |
| 2023-06-30 | -64.38% |
| 2023-03-31 | -131.04% |
| 2022-12-31 | -132.66% |
| 2022-09-30 | -123.77% |
| 2022-06-30 | -105.41% |
| 2022-03-31 | -19.99% |
| 2021-12-31 | -16.33% |
| 2021-09-30 | -24.14% |
| 2021-06-30 | -18.16% |
| 2021-03-31 | -18.43% |
| 2020-12-31 | -33.33% |
| 2020-09-30 | -27.15% |
| 2020-06-30 | -26.36% |
| 2020-03-31 | -40.07% |
| 2019-12-31 | -10.91% |
| 2019-09-30 | -10.33% |
| 2019-06-30 | -8.96% |
| 2019-03-31 | -7.27% |
| 2018-12-31 | -6.00% |
| 2018-09-30 | -12.57% |
| 2018-06-30 | -7.07% |
| 2018-03-31 | -6.16% |
| 2017-12-31 | -4.86% |
| 2017-09-30 | -2.73% |
| 2017-06-30 | -3.72% |
| 2017-03-31 | -4.19% |
| 2016-12-31 | -2.25% |
| 2016-09-30 | -9.48% |
| 2016-06-30 | -5.34% |
| 2016-03-31 | -1.93% |
| 2015-12-31 | 0.82% |
| 2015-09-30 | 0.76% |
| 2015-06-30 | -10.83% |
| 2015-03-31 | -16.89% |
| 2014-12-31 | -34.03% |
| 2014-01-31 | -17.62% |
| 2013-10-31 | -12.90% |
| 2013-07-31 | -15.40% |
| 2013-04-30 | -7.94% |
| 2013-01-31 | -8.33% |
| 2012-10-31 | -7.59% |
| 2012-07-31 | -4.02% |
| 2012-04-30 | -3.56% |
| 2012-01-31 | -3.63% |
| 2011-10-31 | -4.33% |
| 2011-07-31 | -4.19% |
| 2011-04-30 | -4.11% |
| 2011-01-31 | -4.40% |
| 2010-10-31 | -5.02% |
